Develops drugs for Alzheimer's disease.
Sep 2025Revenue $1.11M/yrExpenses $9.20M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will IGC Pharma be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Sep 2025, revenue was $1.11M and expenses $9.20M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2025 | $1.27M | $8.72M | −$7.45M |
| Mar 2024 | $1.34M | $11.1M | −$9.80M |
| Mar 2023 | $911K | $12.5M | −$11.6M |
| Mar 2022 | $397K | $15.8M | −$15.4M |
| Mar 2021 | $898K | $9.62M | −$8.72M |
| Mar 2020 | $4.07M | $10.9M | −$6.86M |
| Mar 2019 | $5.12M | $9.76M | −$4.64M |
| Mar 2018 | $2.19M | $3.98M | −$1.79M |
| Mar 2017 | $580K | $2.63M | −$2.05M |
| Mar 2016 | $6.37M | $9.27M | −$2.91M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.